ID
40953
Beskrivning
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Nyckelord
Versioner (2)
- 2020-04-25 2020-04-25 -
- 2020-06-07 2020-06-07 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
7 juni 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
Medical conditions (Liver MEDHX), Liver Event 5-DF
- StudyEvent: ODM
Beskrivning
Drug related liver disease conditions (All drugs including Investigational Product)
Alias
- UMLS CUI-1
- C0023895
- UMLS CUI-2
- C0277579
Beskrivning
Other liver disease conditions
Beskrivning
[hidden] Item is not required
Datatyp
text
Alias
- UMLS CUI [1]
- C2348184
Beskrivning
Specific Condition
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C2348235
Beskrivning
[hidden] Item is not required
Datatyp
text
Alias
- UMLS CUI [1]
- C2826302
Beskrivning
[hidden]
Datatyp
text
Alias
- UMLS CUI [1]
- C1140263
Beskrivning
[hidden]
Datatyp
text
Alias
- UMLS CUI [1]
- C2347090
Beskrivning
[hidden]
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Beskrivning
Status
Datatyp
integer
Alias
- UMLS CUI [1]
- C0449438
Beskrivning
Other medical conditions
Beskrivning
Drug Allergies
Datatyp
integer
Alias
- UMLS CUI [1]
- C0013182
Beskrivning
Rheumatoid Arthritis
Datatyp
integer
Alias
- UMLS CUI [1]
- C0003873
Beskrivning
Psoriasis
Datatyp
integer
Alias
- UMLS CUI [1]
- C0033860
Beskrivning
Thyroid Disease
Datatyp
integer
Alias
- UMLS CUI [1]
- C0040128
Beskrivning
Inflammatory Bowel Disease
Datatyp
integer
Alias
- UMLS CUI [1]
- C0021390
Beskrivning
Lupus
Datatyp
integer
Alias
- UMLS CUI [1]
- C0409974
Beskrivning
Sjogren's Syndrome
Datatyp
integer
Alias
- UMLS CUI [1]
- C1527336
Beskrivning
Vitiligo
Datatyp
integer
Alias
- UMLS CUI [1]
- C0042900
Similar models
Medical conditions (Liver MEDHX), Liver Event 5-DF
- StudyEvent: ODM
C0262926 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0014644 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C3275124 (UMLS CUI [2])
(Comment:en)
(Comment:en)
(Comment:en)
C0277579 (UMLS CUI-2)
C0277579 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C2348235 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)